Retatrutide

20 mg

Description

Retatrutide, also known as LY3437943, is an investigational peptide that activates GIP, GLP-1 and glucagon receptors. It is being studied in metabolic clinical trials. Research on the molecule does not verify the identity or quality of this catalog product.

Ask about this product

Price & availability via WhatsApp.

Specifications

Brand: Onyx Peptides
Product name: Retatrutide
Labeled quantity: 20 mg
Category: Triple receptor agonist peptide
COA & batch documentation: Varies by batch. Confirm through the Onyx team on WhatsApp.

COAs and test results vary by batch. Artwork does not replace the COA for your product batch. Contact the Onyx team through WhatsApp to confirm the matching documentation.

Confirm the batch COA via WhatsApp

RESEARCH CONTEXT

Understanding the compound.

Investigational molecule; safety and efficacy remain under evaluation in clinical trials.

Research code: LY3437943
Molecular targets: GIPR

Have a question about this compound or product? The Onyx team can help through WhatsApp.

Ask the Onyx team

Back to catalog